Patents by Inventor Garrick Smith

Garrick Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070060574
    Abstract: The invention provides compounds represented by the general formula I wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.
    Type: Application
    Filed: October 19, 2006
    Publication date: March 15, 2007
    Applicant: H. Lundbeck A/S
    Inventors: Thomas Ruhland, Garrick Smith, Benny Bang-Andersen, Ask Puschl, Ejner Moltzen, Kim Andersen
  • Publication number: 20060235003
    Abstract: The present invention relates to compounds of formula I wherein the substituents are as defined below. The compounds of formula are useful for the treatment of diseases such as schizophrenia, including both the positive and the negative symptoms of schizophrenia and other psychoses.
    Type: Application
    Filed: April 27, 2004
    Publication date: October 19, 2006
    Inventors: Garrick Smith, Gitte Mikkelsen, Kim Andersen, Daniel Greve, Jorgen Eskildsen
  • Publication number: 20060089368
    Abstract: The invention provides compounds represented by the general formula I wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.
    Type: Application
    Filed: December 6, 2005
    Publication date: April 27, 2006
    Applicant: H. Lundbeck A/S
    Inventors: Thomas Ruhland, Garrick Smith, Benny Bang-Andersen, Ask Puschl, Ejner Moltzen, Kim Andersen
  • Publication number: 20060084662
    Abstract: The invention provides compounds represented by the general formula I wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.
    Type: Application
    Filed: December 6, 2005
    Publication date: April 20, 2006
    Applicant: H. Lundbeck A/S
    Inventors: Thomas Ruhland, Garrick Smith, Benny Bang-Andersen, Ask Puschl, Ejner Moltzen, Kim Andersen
  • Publication number: 20050171061
    Abstract: The invention provides compounds of the formula wherein the substituents are as defined in the application. The compounds are valuable glycine transport inhibitors.
    Type: Application
    Filed: May 20, 2004
    Publication date: August 4, 2005
    Applicant: H. Lundbeck A/S
    Inventors: Garrick Smith, Gitte Mikkelsen, Kim Andersen, Daniel Greve, Thomas Ruhland, Stephen Wren
  • Publication number: 20050014740
    Abstract: The invention provides compounds represented by the general formula I wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.
    Type: Application
    Filed: October 2, 2002
    Publication date: January 20, 2005
    Inventors: Thomas Ruhland, Garrick Smith, Benny Bang-Andersen, Ask Puschl, Ejner Moltzen, Kim Andersen